Bio-Techne Corp

NASDAQ:TECH

Bio-Techne makes the tools scientists use to study cells and disease. Its products include antibodies, proteins, assays, cell and gene therapy reagents, and instruments used in life-science research and clinical testing. The company also sells diagnostic products that help labs detect and monitor certain medical conditions. Its main customers are drug developers, academic and government research labs, biotech companies, and clinical laboratories. Bio-Techne makes money by selling these consumable products, along with instruments and related services, through direct sales and distributors. Because many of its products are used repeatedly in research and testing workflows, it plays a steady supplier role in the life-science supply chain. What makes Bio-Techne different is that it sits close to the basic science stage of medicine. Instead of making finished drugs, it sells the specialized materials and testing tools that other companies and labs need to discover, develop, and validate those drugs and diagnostics. That gives it exposure to a wide range of research and healthcare end markets.